These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6329773)

  • 1. Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal.
    Wen HL; Ho WK; Wen PY
    Eur J Pharmacol; 1984 Apr; 100(2):155-62. PubMed ID: 6329773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive profiles of opioid peptide agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    Peptides; 1985; 6 Suppl 2():171-5. PubMed ID: 2867529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1981 Nov; 219(2):296-8. PubMed ID: 6116798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motility effects of opioid peptides in dog intestine.
    Burks TF; Hirning LD; Galligan JJ; Davis TP
    Life Sci; 1982 Nov 15-22; 31(20-21):2237-40. PubMed ID: 6298519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of withdrawal symptoms by dynorphin in heroin addicts.
    Wen HL; Ho WK
    Eur J Pharmacol; 1982 Aug; 82(3-4):183-6. PubMed ID: 6127224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid peptides increase calcium uptake by synaptosomes from brain regions.
    Barr E; Leslie SW
    Brain Res; 1985 Mar; 329(1-2):280-4. PubMed ID: 2858254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
    Werz MA; Macdonald RL
    J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased dihydromorphine and D-ALA2-D-LEU5-enkephalin binding in vitro after dynorphin pretreatment in mice in vivo.
    Jen MF; Garzón J; Lee NM
    Life Sci; 1982 Oct 18-25; 31(16-17):1813-6. PubMed ID: 6130446
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    Tseng LF; Cheng SS; Fujimoto JM
    J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of D-Ala2-D-Leu5-enkephalin and dynorphin A (1-17) on neocortical neurons in vitro.
    Sutor B; Zieglgänsberger W
    Neuropeptides; 1984 Dec; 5(1-3):241-4. PubMed ID: 6152323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogenetic development of the pro-enkephalin B (= pro-dynorphin) opioid peptide system in the rat pituitary.
    Seizinger BR; Liebisch DC; Grimm C; Herz A
    Neuroendocrinology; 1984 Nov; 39(5):414-22. PubMed ID: 6151128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
    Nylander I; Vlaskovska M; Terenius L
    Psychopharmacology (Berl); 1995 Apr; 118(4):391-400. PubMed ID: 7568625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.
    Jen MF; Garzon J; Loh HH; Lee NM
    Eur J Pharmacol; 1983 Jul; 91(1):95-9. PubMed ID: 6311575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
    Katoh A; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1990 May; 253(2):600-7. PubMed ID: 1971017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.